Molecular Devices Shares Up 10 Percent on Stock Upgrade | GenomeWeb
NEW YORK (GenomeWeb News) – Shares in Molecular Devices were up around 10 percent, or $2.17, to $24.39 in mid-afternoon trading today after an investment bank yesterday upgraded its stock.
 
Infinium Securities upgraded the stock to “Outperform” from “Underperform” yesterday.
 
The uptick today halted a 16-percent decline in share price that began July 21 when Molecular Devices announced weak second quarter revenue and earnings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.